title: Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups.
authors.forename: D
authors.initials: D
authors.lastname: Mukherjee
authors.forename: J
authors.initials: J
authors.lastname: Fang
authors.forename: E
authors.initials: E
authors.lastname: Kline-Rogers
authors.forename: R
authors.initials: R
authors.lastname: Otten
authors.forename: K A
authors.initials: KA
authors.lastname: Eagle
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012044:Regression Analysis; D012307:Risk Factors; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors